GGrantIndex
← Leaderboards

Vironika, Llc

Wynnewood, PA

Compare ↔
$4,734,680
Total funding
9
Grants

Funding over time

peak $880K · FY2009–23
$1M$750K$500K$250K$0
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23

Funding mix

By agency

NIH$4,734,680 · 9

By mechanism

R43$3,234,680 · 8
R44$1,500,000 · 1

Investigators at Vironika, Llc

Investigator-initiatedAll funding

InvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Exposure= the full size of every grant they're on ($1M each).

Rising Stars

First grant in the last 5 yrs

Not enough data

Emerging Leaders

6–10 yrs in

1Takahiro Yano$1,449,2783 gr2Nelson Delgado$150,0001 gr

All-Time

Most funded here, all years

1Mark E McDonnell$4,736,7004 gr2Troy E Messick$3,405,2673 gr3Takahiro Yano$1,449,2783 gr4Ursula D Ramirez$900,0012 gr5Pieter Van Den Heuvel$505,0002 gr6Nelson Delgado$150,0001 gr

Largest grants

Development of a Small Molecule Inhibitor for EBV Latent Infection$750,000
R44 · FY2014 · AI
Development of a Small Molecule Inhibitor for EBV Latent Infection$750,000
R44 · FY2015 · AI
Development of a Small Molecule Inhibitor for EBV Lytic Reactivation$300,001
R43 · FY2016 · AI
Small Molecule Targeting of Viral Non-Coding RNA EBER1 to Detect and Treat Latent EBV$300,000
R43 · FY2018 · AI
Targeting HIV transcription with RNA-binding small molecules$300,000
R43 · FY2021 · AI
Development of a Small Molecule Inhibitor to Eradicate HSV Latent Infection in Neurons$300,000
R43 · FY2020 · AI
Small Molecule Targeting of Viral Non-Coding RNA EBER1 to Detect and Treat Latent EBV$300,000
R43 · FY2019 · AI
Development of a Small Molecule Inhibitor to Eradicate HSV Latent Infection in Neurons$300,000
R43 · FY2019 · AI
Targeting HIV transcription with RNA-binding small molecules$300,000
R43 · FY2022 · AI
Discovery of inhibitors of EBV lytic cycle inducing protein ZTA for therapeutic development$269,073
R43 · FY2022 · AI
Development of a Small Molecule Inhibitor for EBV Latent Infection$245,577
R43 · FY2012 · AI
Novel Inhibitors of Latent Epstein Barr Virus Infection$192,557
R43 · FY2009 · AI
Discovery of inhibitors of EBV lytic cycle inducing protein ZTA for therapeutic development$130,205
R43 · FY2023 · AI
Stable and Tunable Episomes for Gene Therapy$130,000
R43 · FY2015 · GM
Development of a Small Molecule Inhibitor for EBV Latent Infection$91,124
R43 · FY2013 · AI
Novel Inhibitors of Latent Epstein Barr Virus Infection$76,143
R43 · FY2010 · AI